Flucytosine: Difference between revisions
From IDWiki
(Created page with "== Therapeutic Drug Monitoring == * Measure peak and trough within 72 hours of starting or adjusting dose, adjusting interacting medications, uncertain adherence, or signs of...") Â |
(→â€)  |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
== Therapeutic Drug Monitoring == |
== Therapeutic Drug Monitoring == |
||
* Measure peak and trough within 72 hours of starting or adjusting dose, adjusting interacting medications, uncertain adherence, or signs of toxicity |
* Measure peak and trough within 72 hours of starting or adjusting dose, adjusting interacting medications, uncertain adherence, or signs of toxicity |
||
** Peak measured 2 hours after a dose |
|||
* Target trough 20-40 mg/L and peak <100 mg/L |
* Target trough 20-40 mg/L and peak <100 mg/L |
||
== Adverse Drug Reactions == |
|||
* [[Adverse drug reaction::Neutropenia]] correlates well with levels |
|||
[[Category:Antifungals]] |
[[Category:Antifungals]] |
||
Latest revision as of 03:16, 18 February 2020
Therapeutic Drug Monitoring
- Measure peak and trough within 72 hours of starting or adjusting dose, adjusting interacting medications, uncertain adherence, or signs of toxicity
- Peak measured 2 hours after a dose
- Target trough 20-40 mg/L and peak <100 mg/L
Adverse Drug Reactions
- Neutropenia correlates well with levels
